Sélim Corm

2.7k citations

44 papers · 1.4k indexed · h-index 18

Impact in

Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Hematology 34
- Chronic Myeloid Leukemia Treatments 26
- Acute Myeloid Leukemia Research 9
Genetics 25
- Chronic Lymphocytic Leukemia Research 25

Co-authors: Claude Preudhomme (15 shared papers)Hervé Dombret (4 shared papers)Catherine Roche‐Lestienne (11 shared papers)Lydia Roy (4 shared papers)Bruno Quesnel (9 shared papers)Andreas Hochhaus (5 shared papers)Jeffrey H. Lipton (3 shared papers)François Guilhot (10 shared papers)
Journals: Blood (18 papers)Journal of Clinical Oncology (4 papers)British Journal of Haematology (3 papers)Leukemia Research (3 papers)Leukemia (3 papers)
Partner nations: France United States Canada

In The Last Decade

Sélim Corm

42 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sélim Corm

Since Specialization

Citations

This map shows the geographic impact of Sélim Corm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sélim Corm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sélim Corm more than expected).

Fields of papers citing papers by Sélim Corm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sélim Corm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sélim Corm. The network helps show where Sélim Corm may publish in the future.

Co-authors

The 25 scholars most cited alongside Sélim Corm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sélim Corm Line = papers co-authored together Sélim Corm links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib Leukemia ·Andreas Hochhaus, Michele Baccarani, Michael W. Deininger, Jane F. Apperley, Jeffrey H. Lipton, Stuart L. Goldberg, Sélim Corm, Neil P. Shah, Francisco Cervantes, Richard T. Silver, Dietger Niederwieser, Richard M. Stone, Hervé Dombret, Richard A. Larson, Lydia Roy, Timothy P. Hughes, Martin C. Müller, Rana Ezzeddine, Athena Countouriotis, H. Kantarjian	2008	271
2	Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study Journal of Clinical Oncology ·Cécile Pautas, Fatiha Merabet, Xavier Thomas, Emmanuel Raffoux, Claude Gardin, Sélim Corm, Jean Bourhis, Oumédaly Reman, Pascal Turlure, Nathalie Contentin, Thierry de Revel, Philippe Rousselot, Claude Preudhomme, Dominique Bordessoule, Pierre Fenaux, Christine Terré, Mauricette Michallet, Hervé Dombret, Sylvie Chevret, Sylvie Castaigné	2010	164
3	Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP) Leukemia ·Franck E. Nicolini, Sélim Corm, Q.H. Le, Nathalie Sorel, Sandrine Hayette, Dominique Bories, Thibaut Leguay, Lydia Roy, Stéphane Giraudier, Michel Tulliez, Thierry Façon, F-X Mahon, JM Cayuela, Philippe Rousselot, M. Michallet, Claude Preudhomme, François Guilhot, Catherine Roche‐Lestienne	2006	154
4	l‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial British Journal of Haematology ·Carine Domenech, Xavier Thomas, Sylvie Chabaud, André Baruchel, François Gueyffier, Françoise Mazingue, Anne Auvrignon, Sélim Corm, Hervé Dombret, Patrice Chevallier, Claire Galambrun, Françoise Huguet, Faézeh Legrand, Françoise Méchinaud, Norbert Vey, Irène Philip, D Liens, Yann Godfrin, Dominique Rigal, Yves Bertrand	2011	113
5	Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-γ Leukemia Research ·Sélim Corm, Céline Berthon, M. Imbenotte, Valéria Biggio, Michel Lhermitte, Caroline Dupont, Isabelle Briche, Bruno Quesnel	2008	84
6	Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation Haematologica ·Franck E. Nicolini, Sandrine Hayette, Sélim Corm, Emmanuel Bachy, Dominique Bories, Michel Tulliez, François Guilhot, Laurence Legros, Frédéric Maloisel, Jean‐Jacques Kiladjian, François‐Xavier Mahon, Quoc‐Hung Le, Mauricette Michallet, Catherine Roche‐Lestienne, Claude Preudhomme	2007	51
7	RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance Blood ·Catherine Roche‐Lestienne, Lauréline Deluche, Sélim Corm, Isabelle Tigaud, Sami Joha, N Philippe, Sandrine Geffroy, Jean-Luc Laı̈, Franck‐Emmanuel Nicolini, Claude Preudhomme	2008	50
8	Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia Haematologica ·Étienne Lengliné, Bernard Drénou, Pierre Péterlin, Olivier Tournilhac, Julie Abraham, Ana Berceanu, Brigitte Dupriez, Gaëlle Guillerm, Emmanuel Raffoux, Flore Sicre de Fontbrune, Lionel Adès, Marie Balsat, Driss Chaoui, Paul Coppo, Sélim Corm, Thierry Leblanc, Natacha Maillard, Louis Terriou, Gèrard Socié, Régis Peffault de Latour	2017	45
9	BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism Leukemia ·J Liu, Sami Joha, Thierry Idziorek, Sélim Corm, Dominique Hétuin, N Philippe, Claude Preudhomme, Bruno Quesnel	2008	33
10	Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy Cancer Genetics and Cytogenetics ·Steven Richebourg, Virginie Éclache, Christine Pérot, Marie‐France Portnoï, Jacqueline van den Akker, Christine Terré, Odile Maareck, Valérie Soenen, F Viguié, Jean-Luc Laı̈, Joris Andrieux, Sélim Corm, Catherine Roche‐Lestienne	2008	33
11	Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Imatinib-Resistant Chronic Myeloid Leukemia (CML) Patients Who Harbor the Bcr- Abl T315I Mutation–Results of An Ongoing Multicenter Phase 2/3 Study. Blood ·Jörge E. Cortes, H. Jean Khoury, Franck E. Nicolini, Sélim Corm, Jeffrey H. Lipton, Dan Jones, Andreas Hochhaus, Adam R. Craig, Annie‐Claude Benichou, Eric Humphriss, Hagop M. Kantarjian	2009	32
12	Lenalidomide in lower‐risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis‐stimulating agents British Journal of Haematology ·David Sibon, Giovanna Cannas, F Baracco, Thomas Prébet, Norbert Vey, Anne Banos, Caroline Besson, Sélim Corm, Michel Blanc, Bohrane Slama, Hervé Perrier, Pierre Fenaux, Eric Wattel, (unknown)	2011	29
13	Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology Journal of Clinical Pharmacy and Therapeutics ·B. des Champs-Bro, A. Leroy-Cotteau, Françoise Mazingue, Florence Pasquier, François Nosten, Sélim Corm, L Lemaître, Daniel Poulain, Ibrahim Yakoub‐Agha, S. Alfandari, Boualem Sendid	2010	27
14	Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification Leukemia Research ·Céline Berthon, Michaëla Fontenay, Sélim Corm, Isabelle Briche, Delphine Allorge, Benjamin Hennart, Michel Lhermitte, Bruno Quesnel	2013	26
15	Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC study Current Medical Research and Opinion ·Mauricette Michallet, Michel Tulliez, Sélim Corm, Martine Gardembas, Françoise Huguet, Abderrahim Oukessou, B. Bregman, Anne Vekhoff, Kamel Ghomari, Nathalie Cambier, Agnès Guerci‐Bresler	2009	23
16	Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study Blood ·Sélim Corm, Laurent Roche, Jean‐Baptiste Micol, Valérie Coiteux, Nadine Bossard, Franck-Emmanuel Nicolini, Jean Iwaz, Claude Preudhomme, Catherine Roche‐Lestienne, Thierry Façon, Laurent Remontet	2011	22
17	Administration of alemtuzumab and G‐CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study European Journal Of Haematology ·Norbert Claude Gorin, Françoise Isnard, Laurent Garderet, Souhila Ikhlef, Sélim Corm, Bruno Quesnel, Ollivier Legrand, Marine Cachanado, Alexandra Rousseau, Jean‐Philippe Laporte	2013	20
18	A Phase II Study of Dasatinib in Patients with Chronic Myeloid Leukemia (CML) in Myeloid Blast Crisis Who Are Resistant or Intolerant to Imatinib: First Results of the CA180006 ‘START-B’ Study. Blood ·Moshe Talpaz, P Rousselot, D.W. Kim, François Guilhot, Sélim Corm, Eric Bleickardt, Richard C. Zink, G. Rosti, Steven Coutré, Charles L. Sawyers	2005	20
19	Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia Médecine et Maladies Infectieuses ·C. Hochart, Céline Berthon, Sélim Corm, Jason Gay, Manuel Cliquennois, Sabine Tricot, S. Alfandari	2011	15
20	Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome British Journal of Haematology ·Nathalie Douet‐Guilbert, J L Laï, Audrey Basinko, Nadia Guéganic, Joris Andrieux, Bertrand Pollet, Isabelle Plantier, C. Delattre, O. Crépin, Sélim Corm, M.‐J. Le Bris, Fréderic Morel, Marc De Braekeleer	2008	13

About Sélim Corm

Sélim Corm is a scholar working on Hematology, Genetics, Biological Psychiatry, Rheumatology and Pathology and Forensic Medicine, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (26 papers), Chronic Lymphocytic Leukemia Research (25 papers), Eosinophilic Disorders and Syndromes (12 papers), Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Neutropenia and Cancer Infections (4 papers) and Tryptophan and brain disorders (3 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (715 citations), Rheumatology (444 citations), Biological Psychiatry (61 citations) and Oncology (192 citations). Sélim Corm has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Claude Preudhomme, Hervé Dombret, Catherine Roche‐Lestienne, Lydia Roy, Bruno Quesnel, Andreas Hochhaus, Jeffrey H. Lipton, François Guilhot, Céline Berthon and Xavier Thomas. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Leukemia Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact